stockrowNewAmsterdam Pharma Company N.V.
NAMS Healthcare Biotechnology
NewAmsterdam Pharma Company N.V.’s revenue for fiscal 2025 (year ended December 2025) was $22.5 million, down 50.6% from fiscal 2024.
- Revenue
- +5,406.9%
- EPS
- +77.1%
- Free cash flow
- −21.8%
Quarter to September 2026, against a year earlier
Follow NAMS
Alert me
NewAmsterdam Pharma Company N.V. (NAMS) Operating margin
NewAmsterdam Pharma Company N.V.'s operating margin over the twelve months to 30 September 2026 was −900.1%, up 102.8 percentage points from fiscal 2025 (−1,002.9%). Over the past ten years it has ranged from −1,298.6% (fiscal 2023) to 0.00% (fiscal 2021); the current reading is higher than 22% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −1,002.9% | (615.99) |
| FY2024 | −386.9% | 911.65 |
| FY2023 | −1,298.6% | (1,295.10) |
| FY2022 | −3.46% | 6.35 |
| FY2022 | −9.81% | (9.81) |
| FY2021 | 0.00% | 0.00 |
| FY2021 | 0.00% | 0.00 |
| FY2020 | 0.00% | 0.00 |
| FY2020 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −230.6% | 1,522.03 |
| Jun 2026 | −1,752.6% | 169.10 |
| Mar 2026 | −1,921.7% | 204,265.79 |
| Dec 2025 | −206,187.5% | (190,341.81) |
| 19 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ADMA ADMA Biologics Inc compare | 46.5% |
| MBX MBX Biosciences, Inc. compare | 0.00% |
| PHVS Pharvaris N.V. compare | 0.00% |
| PVLA Palvella Therapeutics, Inc. compare | 0.00% |
| ZLAB Zai Lab Limited Unsponsored ADR compare | −63.0% |
| XNCR Xencor, Inc. compare | −205.8% |
| RXRX Recursion Pharmaceuticals, Inc. compare | −725.4% |
| NAMS NewAmsterdam Pharma Company N.V. | −900.1% |
| CLDX Celldex Therapeutics, Inc. compare | −36,733.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on NAMS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Altman Z-score
- The full statement